Virtual Library

Start Your Search

  • TTLC 2019

    IASLC 2019 Targeted Therapies of Lung Cancer Meeting

    Access to all slides from presentations that occur during the IASLC 2019 Targeted Therapies of Lung Cancer Meeting in Santa Monica, CA

    Presentation Date(s):  
    • Feb 20 - 23, 2019
    • Total Presentations: 232

    IASLC Member Price: $95.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    11 - Surgically Resectable

    • Type: General Session
    • Track:
    • Presentations: 10
    • Slides Available
    • +

      Surgery Considerations After IO or TKI (Slides Available)

      07:00 - 07:05  |  Author(s): Erin Gillaspie

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Neoadjuvant Atezolizumab (LCMC3) and Pembrolizumab (Slides Available)

      07:05 - 07:10  |  Author(s): Jay Lee

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Neoadjuvant Chemo + Atezolizumab (Slides Available)

      07:10 - 07:15  |  Author(s): Catherine Shu

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Neoadjuvant Nivolumab +/- Ipilimumab (NEOSTAR) (Slides Available)

      07:15 - 07:20  |  Author(s): Tina Cascone

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Adjuvant IO (Slides Available)

      07:20 - 07:25  |  Author(s): Penelope Bradbury

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Adjuvant Alchemist ALK TKIs (Slides Available)

      07:25 - 07:30  |  Author(s): David Gerber

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Osimertinib EGFR Mutant (Slides Available)

      07:30 - 07:35  |  Author(s): Collin Blakely

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Neoadjuvant Crizotinib ALK ROS and MET (Slides Available)

      07:35 - 07:40  |  Author(s): Caroline McCoach

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      LCMC4 Umbrella (Slides Available)

      07:40 - 07:45  |  Author(s): Jamie Chaft

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Science (Slides Available)

      07:45 - 07:55  |  Author(s): David Harpole

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    12 - Debate #2 Neoadjuvant/Adjuvant CT+IO Is Most Likely to Cure the Most Patients

    • Type: General Session
    • Track:
    • Presentations: 2
    • Slides Available
  • +

    13 - Vaccines and Agents Targeting Tumor Microenvironment

    • Type: General Session
    • Track:
    • Presentations: 8
    • Slides Available
  • +

    14 - HER2/3 and Exon 20

    • Type: General Session
    • Track:
    • Presentations: 12
    • Slides Available
    • +

      Poziotinib (Slides Available)

      09:45 - 09:50  |  Author(s): Jacqulyne Robichaux

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Osimertinib (Slides Available)

      09:50 - 09:55  |  Author(s): Zofia Piotrowska

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Tak 788 (Slides Available)

      09:55 - 10:00  |  Author(s): Jack West

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Tarloxotinib (Hypoxia Activated EGFR) (Slides Available)

      10:00 - 10:05  |  Author(s): Viola Zhu

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Trastuzumab and Ado-trastuzumab (Slides Available)

      10:05 - 10:10  |  Author(s): Bob Li

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Pertuzumab (HER 2) (Slides Available)

      10:10 - 10:15  |  Author(s): Thomas Stinchcombe

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      DS8201 (Trastuzumab Derutecam) (Slides Available)

      10:15 - 10:20  |  Author(s): Pasi Janne

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      TAS0728 (HER 2)

      10:20 - 10:25  |  Author(s): Rathi Pillai

      • Abstract

      Abstract not provided

    • +

      Pyrotinib (HER 2) (Slides Available)

      10:25 - 10:30  |  Author(s): George Simon

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MM 121 Seribentumab

      10:30 - 10:35  |  Author(s): Lecia Sequist

      • Abstract

      Abstract not provided

    • +

      ADCT-502 (HER 2 ADC)

      10:35 - 10:40  |  Author(s): Grace Dy

      • Abstract

      Abstract not provided

    • +

      Where to Next?

      10:40 - 10:50  |  Author(s): Robert Doebele

      • Abstract

      Abstract not provided

  • +

    15 - Stage 3 NSCLC

    • Type: General Session
    • Track:
    • Presentations: 9
    • Slides Available
  • +

    16 - Best Fellows Abstract Oral Presentations

    • Type: General Session
    • Track:
    • Presentations: 4
    • Slides Available
    • +

      IL-6, IL-8 Drive LAG3/PD1 Immune Suppression on Effector and Naïve, Peripheral Blood CD8+ T Cells in Lung Cancer Patients (Slides Available)

      13:00 - 13:10  |  Author(s): Ashwin Somasundaram

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Standardization of Tumor Mutational Burden (TMB) Quantification and Thresholds in NSCLC (Slides Available)

      13:15 - 13:25  |  Author(s): Natalie Vokes

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Neoadjuvant Nivolumab in Resectable Non-small Cell Lung Cancer: Long-term Clinical Follow-up With Longitudinal Molecular and Immunologic Responses (Slides Available)

      13:30 - 13:40  |  Author(s): Joshua Reuss

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      The Molecular Landscape of Resistance to Osimertinib in EGFR-mutant Non-small Cell Lung Cancers

      13:45 - 13:55  |  Author(s): Adam Schoenfeld

      • Abstract

      Abstract not provided

  • +

    17 - Miscellaneous

    • Type: General Session
    • Track:
    • Presentations: 13
    • Slides Available
  • +

    18 - MET/RET

    • Type: General Session
    • Track:
    • Presentations: 14
    • Slides Available
    • +

      BLU667 (RET) (Slides Available)

      15:40 - 15:45  |  Author(s): Justin Gainor

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      RXDX104/015 (RET) (Slides Available)

      15:45 - 15:50  |  Author(s): Jyoti Patel

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Loxo 292 (RET) (Slides Available)

      15:50 - 15:55  |  Author(s): Alexander Drilon

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Multi TKIs (Cabo, Levantinib, Alectinib, Ponatinib) (RET) (Slides Available)

      15:55 - 16:00  |  Author(s): Adrian Sacher

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Crizotinib (MET) (Slides Available)

      16:00 - 16:05  |  Author(s): Mark Kris

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Capmatinib (MET) (Slides Available)

      16:05 - 16:10  |  Author(s): Rebecca Heist

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Tepotinib (MET) (Slides Available)

      16:10 - 16:15  |  Author(s): Xiuning Le

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Cabozantinib (MET) (Slides Available)

      16:15 - 16:20  |  Author(s): Joel Neal

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Savolitinib (MET) (Slides Available)

      16:20 - 16:25  |  Author(s): Mark Awad

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Emibetuzumab (MET) (Slides Available)

      16:25 - 16:30  |  Author(s): Ron Natale

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Sym015 (MET) (Slides Available)

      16:30 - 16:35  |  Author(s): Ross Camidge

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      TPX0022 (MET) (Slides Available)

      16:35 - 16:40  |  Author(s): Joel Neal

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Merestinib (AXL) (Slides Available)

      16:40 - 16:45  |  Author(s): Mark Awad

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Science (Slides Available)

      16:45 - 16:55  |  Author(s): Trever Bivona

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    19 - Debate #3 Optimal Therapy After Progression on Osimertinib with No New Driver is Chemotherapy Alone

    • Type: General Session
    • Track:
    • Presentations: 2
    • Slides Available
    • +

      No - Chemo + IO + Bev

      17:05 - 17:20  |  Author(s): Karen Kelly

      • Abstract

      Abstract not provided

    • +

      Yes - Chemo Alone (Slides Available)

      17:05 - 17:20  |  Author(s): Frances Shepherd

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    20 - Mesothelioma

    • Type: General Session
    • Track:
    • Presentations: 7
    • Slides Available